Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle

Interleukin-1 beta (IL-1) reduces vascular smooth muscle contractility. The purpose of the present study was to investigate the role of nitric oxide synthesis in mediating this effect of IL-1. We studied the influence of inhibitors of nitric oxide synthesis on the depression of norepinephrine-induce...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pharmacology and experimental therapeutics Vol. 259; no. 1; pp. 260 - 264
Main Authors FRENCH, J. F, LAMBERT, L. E, DAGE, R. C
Format Journal Article
LanguageEnglish
Published Bethesda, MD American Society for Pharmacology and Experimental Therapeutics 01.10.1991
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Interleukin-1 beta (IL-1) reduces vascular smooth muscle contractility. The purpose of the present study was to investigate the role of nitric oxide synthesis in mediating this effect of IL-1. We studied the influence of inhibitors of nitric oxide synthesis on the depression of norepinephrine-induced contractions of rat aortic rings by IL-1. Also, we examined the ability of IL-1 to increase the production of nitric oxide by rat aortic smooth muscle cells in culture as determined indirectly by measuring nitrite concentrations. NG-amino-L-arginine blocked the effect of IL-1 on norepinephrine-induced contractions of rat aortic rings whereas NG-monomethyl-L-arginine and NG-nitro-L-arginine were considerably less effective. In addition, this effect of IL-1 was prevented by coincubation of the rings with cycloheximide. IL-1 greatly elevated nitrite production by rat aortic smooth muscle cells, and this effect could also be blocked completely by the arginine analogs. NG-amino-L-arginine was the most potent inhibitor of nitrite synthesis (IC50 = 1.7 microM) whereas NG-monomethyl-L-arginine and NG-nitro-L-arginine were about 10-fold less potent (IC50 = 16 and 22 microM, respectively). These results suggest that IL-1-induced depression of norepinephrine-induced vascular contraction is mediated by the increased synthesis of nitric oxide synthase by vascular smooth muscle cells. The relative potency of the arginine analogs for the inhibition of nitrite synthesis suggests that the synthase in vascular smooth muscle is similar to the synthase in macrophages.
AbstractList Interleukin-1 beta (IL-1) reduces vascular smooth muscle contractility. The purpose of the present study was to investigate the role of nitric oxide synthesis in mediating this effect of IL-1. We studied the influence of inhibitors of nitric oxide synthesis on the depression of norepinephrine-induced contractions of rat aortic rings by IL-1. Also, we examined the ability of IL-1 to increase the production of nitric oxide by rat aortic smooth muscle cells in culture as determined indirectly by measuring nitrite concentrations. NG-amino-L-arginine blocked the effect of IL-1 on norepinephrine-induced contractions of rat aortic rings whereas NG-monomethyl-L-arginine and NG-nitro-L-arginine were considerably less effective. In addition, this effect of IL-1 was prevented by coincubation of the rings with cycloheximide. IL-1 greatly elevated nitrite production by rat aortic smooth muscle cells, and this effect could also be blocked completely by the arginine analogs. NG-amino-L-arginine was the most potent inhibitor of nitrite synthesis (IC50 = 1.7 microM) whereas NG-monomethyl-L-arginine and NG-nitro-L-arginine were about 10-fold less potent (IC50 = 16 and 22 microM, respectively). These results suggest that IL-1-induced depression of norepinephrine-induced vascular contraction is mediated by the increased synthesis of nitric oxide synthase by vascular smooth muscle cells. The relative potency of the arginine analogs for the inhibition of nitrite synthesis suggests that the synthase in vascular smooth muscle is similar to the synthase in macrophages.
Interleukin-1 beta (IL-1) reduces vascular smooth muscle contractility. The purpose of the present study was to investigate the role of nitric oxide synthesis in mediating this effect of IL-1. We studied the influence of inhibitors of nitric oxide synthesis on the depression of norepinephrine-induced contractions of rat aortic rings by IL-1. Also, we examined the ability of IL-1 to increase the production of nitric oxide by rat aortic smooth muscle cells in culture as determined indirectly by measuring nitrite concentrations. NG-amino-L-arginine blocked the effect of IL-1 on norepinephrine-induced contractions of rat aortic rings whereas NG-monomethyl-L-arginine and NG-nitro-L-arginine were considerably less effective. In addition, this effect of IL-1 was prevented by coincubation of the rings with cycloheximide. IL-1 greatly elevated nitrite production by rat aortic smooth muscle cells, and this effect could also be blocked completely by the arginine analogs. NG-amino-L-arginine was the most potent inhibitor of nitrite synthesis (IC50 = 1.7 microM) whereas NG-monomethyl-L-arginine and NG-nitro-L-arginine were about 10-fold less potent (IC50 = 16 and 22 microM, respectively). These results suggest that IL-1-induced depression of norepinephrine-induced vascular contraction is mediated by the increased synthesis of nitric oxide synthase by vascular smooth muscle cells. The relative potency of the arginine analogs for the inhibition of nitrite synthesis suggests that the synthase in vascular smooth muscle is similar to the synthase in macrophages.
Author J F French
R C Dage
L E Lambert
Author_xml – sequence: 1
  givenname: J. F
  surname: FRENCH
  fullname: FRENCH, J. F
  organization: Marion Merrell Dow res. inst., Cincinnati OH, United States
– sequence: 2
  givenname: L. E
  surname: LAMBERT
  fullname: LAMBERT, L. E
  organization: Marion Merrell Dow res. inst., Cincinnati OH, United States
– sequence: 3
  givenname: R. C
  surname: DAGE
  fullname: DAGE, R. C
  organization: Marion Merrell Dow res. inst., Cincinnati OH, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5044919$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/1717680$$D View this record in MEDLINE/PubMed
BookMark eNpFkMtKxDAUhoOMjOPoIwhZiLtCLk0vSxm8waAbXZfT9HQabZMxSdV5ewtWXf0Hvo9zOyUL6ywekRVXgieMM7kgK8aESKTK1Ak5DeGVMZ6mmVySJc95nhVsRbpHE73R1H2ZBmk42NhBQGpsZ2oTnQ-_5ZQRfY_jm7EJpzVGSIxtRo0NbXDvMQTjLHUt_YCgxx48DYNzsaPDGHSPZ-S4hT7g-Zxr8nJ787y5T7ZPdw-b623SiSyLiZalaDQALwD0tKSQKWO51FAAslbXqm1lJmRbNFKJtih4UWCZYYmlEiydyJpc_fTde_c-YojVYILGvgeLbgxVLnjKWa4m8WIWx3rAptp7M4A_VPNrJn458-ke6FsPVpvwpymWpiUv_-d1Ztd9Go_VvgM_gHa92x0qocqKVyJj8hvw5n31
CODEN JPETAB
ContentType Journal Article
Copyright 1992 INIST-CNRS
Copyright_xml – notice: 1992 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-0103
EndPage 264
ExternalDocumentID 1717680
5044919
259_1_260
Genre Journal Article
GroupedDBID -
08R
0R
2WC
3O-
4.4
53G
55
5GY
5RE
8RP
AALRV
ABFLS
ABIVO
ABOCM
ABSGY
ABZEH
ACGFS
ACNCT
ADBIT
ADCOW
ADKFC
AENEX
AETEA
AFFNX
AIKQT
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DL
DU5
EBS
EJD
F5P
FH7
GJ
GX1
H13
HZ
INIJC
KQ8
L7B
LSO
MVM
O9-
OK1
P2P
R.V
R0Z
RHF
RHI
RPT
VH1
W2D
WH7
WOQ
X
X7M
ZGI
ZXP
---
-~X
.55
.GJ
0R~
18M
5VS
8W4
8WZ
A6W
AAYOK
ABSQV
ACGFO
ADBBV
ADGIM
AFHIN
AFOSN
AGFXO
AI.
BAWUL
BTFSW
E3Z
F9R
HZ~
IQODW
MJL
OHT
TR2
UQL
W8F
YBU
YHG
YQT
AAJMC
ABCQX
ABJNI
ADIYS
AERNN
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-h266t-c392dcaa18aac7172340073ca8ae0fcb5ff3623f8d352f88188e96e9e95204623
ISSN 0022-3565
IngestDate Fri Oct 25 00:18:22 EDT 2024
Sat Sep 28 07:16:20 EDT 2024
Fri Nov 25 16:31:32 EST 2022
Tue Jan 05 21:17:24 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Rat
Rodentia
Contractility
Electrophysiology
Interleukin 1β
Smooth muscle
Muscle contraction
Vertebrata
Mammalia
Blood vessel
Nitrogen monoxide
Aorta
Circulatory system
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-h266t-c392dcaa18aac7172340073ca8ae0fcb5ff3623f8d352f88188e96e9e95204623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 1717680
PQID 72141075
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_72141075
pubmed_primary_1717680
pascalfrancis_primary_5044919
highwire_pharmacology_259_1_260
ProviderPackageCode RHF
RHI
PublicationCentury 1900
PublicationDate 1991-10-01
PublicationDateYYYYMMDD 1991-10-01
PublicationDate_xml – month: 10
  year: 1991
  text: 1991-10-01
  day: 01
PublicationDecade 1990
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle The Journal of pharmacology and experimental therapeutics
PublicationTitleAlternate J Pharmacol Exp Ther
PublicationYear 1991
Publisher American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: American Society for Pharmacology and Experimental Therapeutics
SSID ssj0014463
Score 1.6235874
Snippet Interleukin-1 beta (IL-1) reduces vascular smooth muscle contractility. The purpose of the present study was to investigate the role of nitric oxide synthesis...
Interleukin-1 beta (IL-1) reduces vascular smooth muscle contractility. The purpose of the present study was to investigate the role of nitric oxide synthesis...
SourceID proquest
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 260
SubjectTerms 1-Methyl-3-isobutylxanthine - pharmacology
Amino Acid Oxidoreductases - antagonists & inhibitors
Animals
Arginine - analogs & derivatives
Arginine - pharmacology
Biological and medical sciences
Blood vessels and receptors
Cells, Cultured
Fundamental and applied biological sciences. Psychology
Interleukin-1 - antagonists & inhibitors
Interleukin-1 - pharmacology
Male
Muscle, Smooth, Vascular - drug effects
Nitric Oxide - pharmacology
Nitric Oxide Synthase
Nitroarginine
Norepinephrine - antagonists & inhibitors
Norepinephrine - pharmacology
Rats
Rats, Inbred Strains
Vasoconstriction - drug effects
Vertebrates: cardiovascular system
Title Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle
URI http://jpet.aspetjournals.org/content/259/1/260.abstract
https://www.ncbi.nlm.nih.gov/pubmed/1717680
https://search.proquest.com/docview/72141075
Volume 259
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKnnhBfE0UGPiB7aVL1CROmjx2JaxCrEJVJ_Utsh1HzdiSaU0k4B_xyg_hN3EdO4lbgfh4iaxUdV2fk5tr-95zEXrDWRD67phbAvwFi0TEsRgj8LhHoR8wxqOUynzni0UwvyTv1_56MPhmRC3VFbP511_mlfwPqnAPcJVZsv-AbNcp3IA24AtXQBiuf4XxIpf6-qPyc54KqT1QbeCdNMqLTc7ypoqObjaiEHfXov6UF5ZzPIuPz1wLFuO1PPzvYmEbx7GLTN3elADi6Kbetj961RPLcGNve-1rJeW0UzPASO_qE02W8WI2b-hj94HFH6YXZ_Fy1ewT2H1-xNvpeROvubT1fm6qU_acLtatMpICpLUy4lA_7g8uNge32h-cmXmgakvYQhtsV26HjD3TortaZNykrrbPqniBftW7SkB9V4V77-3YxSz6Y0IiKTB7z3Nk7Oj5uoslkmtqr5Ol96Wj0qlNy2BbQI5eZ6pQyu9XMo1Hs3qIHmgM8VTx6hEaiOIxOtFT9uUUm9Nzik-wOZlPkFDkww35cEs-3JOvbeId8v343hIP98TDZYZb4mFFPKyI9xRdvotXs7mla3ZYG3D1KouDv51ySp2QUj4B79gj8jCY05CKccaZn2XgMnlZmILnn4XgLoYiCkQkIrAYBD45RAdFWYhnCDvUSYkrxaR4RFziMRGRkBIiJegEdDVEr9tJTkyuJwB_4iQA9RAd7cx9cqsUXBKNJfTQYpGAVZVHZbQQZb1NJq6Mf574Q3SoIOq-6sCfCsLx8z90_QLd7x-Fl-iguqvFEbivFXvVUOcniminaQ
link.rule.ids 315,783,787
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nitric+oxide+synthase+inhibitors+inhibit+interleukin-1%CE%B2-induced+depression+of+vascular+smooth+muscle&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=FRENCH%2C+J.+F&rft.au=LAMBERT%2C+L.+E&rft.au=DAGE%2C+R.+C&rft.date=1991-10-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=259&rft.issue=1&rft.spage=260&rft.epage=264&rft.externalDBID=n%2Fa&rft.externalDocID=5044919
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon